<DOC>
	<DOCNO>NCT00349791</DOCNO>
	<brief_summary>This study design evaluate efficacy safety testosterone patch treatment low libido naturally menopausal woman take estrogen estrogen/progestin therapy .</brief_summary>
	<brief_title>Study Assess Efficacy/Safety Transdermal Testosterone Patches Naturally Menopausal Women With Low Libido</brief_title>
	<detailed_description>Naturally menopausal woman hypoactive sexual desire disorder ( HSDD ) randomize 24-week , multicenter , multinational , double-blind ( DB ) , parallel-group , placebo-controlled study . Patients randomize receive placebo testosterone transdermal system throughout study . Safety assess adverse event , lipid , serum chemistry hepatic , renal carbohydrate metabolism evaluation , hematology . Physical exam include clinical assessment facial hair acne monitor .</detailed_description>
	<mesh_term>Hypokinesia</mesh_term>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Eligible woman must : 1 . Be 4070 year old generally good health 2 . Be postmenopausal spontaneous period 1 year 3 . Be receive stable dose hormone replacement therapy least 3 month pror screen intention maintain regimen . 4 . Be , judgment , stable , monogamous sexual relationship perceive secure communicative , least one year prior study entry 5 . Meet criterion hypoactive sexual desire disorder Eligible woman must : 1 . Have receive androgen therapy time past 3 month ( past 7 month therapy investigational implantable product ) 2 . Be experience chronic acute life stress relate major life change 3 . Be experience depression and/or receive medication illness disorder 4 . Have current severe skin problem ( severe cystic acne ) allergy adhesive ( like one bandage ) 5 . Have major illness , active gall bladder disease , gynecological breast surgery within last 6 month 6 . Have history breast , endometrial , gynecological cancer time study participation cancer within last 5 year 7 . Have diabetes , history cerebrovascular disease , thromboembolic disorder , heart attack , angina time study participation thrombophlebitis within last 5 year 8 . Have abnormal laboratory test result upon initial screen study 9 . Have previously participate clinical trial within 30 day receive investigational medication within 30 day</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Natural Menopause</keyword>
</DOC>